Company: VERA
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029969
Chunk: 156

Company: Vera Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 156
---
 Company’s capital stock (including all classes of the Company’s common stock) outstanding on December 31 of the preceding year, or such lower number of shares (including no shares) approved by the Company’s board of directors prior to January 1 of a given year. As of December 31, 2024, 88,752 shares have been issued pursuant to the ESPP. The ESPP generally provides for six-month consecutive offering periods beginning on September 14, 2021. The ESPP is a compensatory plan as defined by the authoritative guidance for stock compensation. The table below summarizes the Company's equity plans as of December 31, 2024: 

        Plan
         
        Maximum Number of Shares Authorized

        Shares Available for Future Issuance

        2024 Inducement Plan

        1,250,000

        71,075

        2021 Equity Incentive Plan

        6,873,404

        682,278

        2017 Equity Incentive Plan

        2,275,305

        —

        2021 Employee Stock Purchase Plan

        1,148,444

        1,059,692

      Option Activity Stock option activity under the 2017 EIP, 2021 EIP, and 2024 Inducement Plan is summarized as follows:  

        Number of Options

        Weighted-Average Exercise Price per Share

        Weighted-Average Remaining Contractual Life (Years)

        Aggregate Intrinsic Value (000s)

        Outstanding as of December 31, 2023

        5,762,236

        $
        9.42

        7.66

        $
        39,197

        Granted

        2,799,750

        $
        25.83

        Exercised

        (1,486,314
        )
         
        $
        8.66

        Cancelled and forfeited

        (463,875
        )
         
        $
        10.93

        Outstanding as of December 31, 2024

        6,611,797

        $
        16.44

        8.11

        $
        172,630

        Options exercisable as of December 31, 2024

        2,703,670

        $
        9.65

        7.11